Literature DB >> 15101497

The neuropsychiatry of multiple sclerosis.

Anthony Feinstein1.   

Abstract

This review describes the many neuropsychiatric abnormalities associated with multiple sclerosis (MS). These may be broadly divided into 2 categories: disorders of mood, affect, and behaviour and abnormalities affecting cognition. With respect to the former, the epidemiology, phenomenology, and theories of etiology are described for the syndromes of depression, bipolar disorder, euphoria, pathological laughing and crying, and psychosis attributable to MS. The section discussing cognition reviews the prevalence and nature of cognitive dysfunction, with an emphasis on abnormalities affecting multiple domains of memory, speed of information processing, and executive function. The detection, natural history, and cerebral correlates of cognitive dysfunction are also discussed. Finally, treatment pertaining to all these disorders is reviewed, with the observation that translational research has been found wanting when it comes to providing algorithms to guide clinicians. Guidelines derived from general psychiatry still largely apply, although they may not always be most effective in patients with neurologic disorders. The importance of future research addressing this imbalance is emphasized, for neuropsychiatric sequelae add significantly to the morbidity associated with MS.

Entities:  

Mesh:

Year:  2004        PMID: 15101497     DOI: 10.1177/070674370404900302

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  33 in total

1.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

Review 2.  [Cognitive dysfunctions in multiple sclerosis patients].

Authors:  C Engel; B Greim; U K Zettl
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

3.  Isolated progressive cognitive impairment and depression in a patient with neuroradiological features suggestive of multiple sclerosis.

Authors:  Diana Ferraro; Anna Maria Simone; Elisa Merelli; Jessica Mandrioli; Maria Angela Molinari; Paolo Frigio Nichelli; Patrizia Sola
Journal:  Neurol Sci       Date:  2011-04-16       Impact factor: 3.307

Review 4.  Diagnosis and treatment of multiple sclerosis.

Authors:  T J Murray
Journal:  BMJ       Date:  2006-03-04

5.  Clinical relevance of circadian melatonin release in relapsing-remitting multiple sclerosis.

Authors:  Simone Kern; Michael Geiger; Madlen Paucke; Alina Kästner; Katja Akgün; Tjalf Ziemssen
Journal:  J Mol Med (Berl)       Date:  2019-08-30       Impact factor: 4.599

Review 6.  Depression in multiple sclerosis: a review.

Authors:  R J Siegert; D A Abernethy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

Review 7.  Transcranial magnetic stimulation for the treatment of depression in neurologic disorders.

Authors:  Felipe Fregni; Alvaro Pascual-Leone
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 8.  Update on depression in neurologic illness: stroke, epilepsy, and multiple sclerosis.

Authors:  Richard M Sobel; Susan Lotkowski; Steven Mandel
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

9.  Affective Temperament Profiles in Patients with Multiple Sclerosis: Association with Mood Disorders.

Authors:  Adile Özkan; Kürşat Altinbaş; Emine Rabia Koç; Halil Murat Şen; Handan Işın Özişik Karaman
Journal:  Noro Psikiyatr Ars       Date:  2015-10-22       Impact factor: 1.339

10.  Secondary psychoses: an update.

Authors:  Matcheri S Keshavan; Yoshio Kaneko
Journal:  World Psychiatry       Date:  2013-02       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.